CLEC11A基因在结直肠癌中的表达差异及临床意义
Expression Difference and Clinical Significance of CLEC11A Gene in Colorectal Cancer
DOI: 10.12677/acm.2025.1551630, PDF,   
作者: 薛建飞*, 吴紫文, 江 兵#:安徽医科大学附属巢湖医院胃肠外科,安徽 巢湖
关键词: CLEC11A结直肠癌免疫浸润甲基化富集分析CLEC11A Colorectal Cancer Immune Infiltration Methylation Enrichment Analysis
摘要: 目的:研究CLEC11A基因在结直肠癌患(CRC)者中的表达差异及临床意义,寻求结直肠癌筛查治疗新靶点。方法:基于TIMER2.0数据库、UALCAN数据库、GEPIA2.0数据库在线分析CLEC11A在泛癌中表达差异;进一步展开生存预后分析、临床病理特征分析、免疫浸润、甲基化、富集分析等深入探讨CLEC11A与CRC发生转归间潜在联系。结果:CLEC11A在CRC中较正常组织高度表达,与患者预后呈负相关。CLEC11A与CD8+ T细胞、CD4+ T细胞、巨噬细胞、中性粒细胞的浸润水平呈正相关,与B细胞的浸润水平呈负相关。CLEC11A甲基化水平同CRC患者年龄存在显著相关性。GO与KEGG富集分析显示共表达基因在伤口愈合、自噬调节、细胞外基质组成及癌症的转录失调等多方面富集。结论:CLEC11A与CRC不良预后密切相关,可能是CRC潜在诊疗靶点。
Abstract: Objectives: To study the expression differences and clinical significance of the CLEC11A gene in patients with colorectal cancer (CRC) and seek new targets for CRC screening and treatment. Methods: Based on the TIMER2.0 database, UALCAN database, and GEPIA2.0 database, the expression differences of CLEC11A in pan-cancers were analyzed online. Survival prognosis analysis, clinicopathological feature analysis, immune infiltration, methylation, and enrichment analysis were further carried out to deeply explore the potential connection between CLEC11A and the occurrence and prognosis of CRC. Results: CLEC11A was highly expressed in CRC compared with normal tissues and was negatively correlated with the prognosis of patients. CLEC11A was positively correlated with the infiltration levels of CD8+ T cells, CD4+ T cells, macrophages, and neutrophils, and negatively correlated with the infiltration level of B cells. The methylation level of CLEC11A was significantly correlated with the age of CRC patients. GO and KEGG enrichment analyses showed that the co-expressed genes were enriched in multiple aspects such as wound healing, autophagy regulation, extracellular matrix composition, and transcriptional dysregulation in cancer. Conclusion: CLEC11A is closely related to the poor prognosis of CRC and may be a potential diagnosis and treatment target for CRC.
文章引用:薛建飞, 吴紫文, 江兵. CLEC11A基因在结直肠癌中的表达差异及临床意义[J]. 临床医学进展, 2025, 15(5): 2381-2392. https://doi.org/10.12677/acm.2025.1551630

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
[3] Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Erratum to Cancer Statistics, 2024(vol 74, pg 12-49, 2024). CA: A Cancer Journal for Clinicians, 74, 203-203.
[4] 郑荣寿, 孙可欣, 张思维, 等. 2015 年恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19-28.
[5] 郭兰伟, 张兴龙, 蔡林, 等. 全球结直肠癌流行和防控现状[J]. 中华肿瘤杂志, 2024, 46(1): 57-65.
[6] Frezza, E.E., Wachtel, M.S. and Chiriva-Internati, M. (2006) Influence of Obesity on the Risk of Developing Colon Cancer. Gut, 55, 285-291.
[7] Liedauer, D.I.F.H.R. (2019) The Prognostic Relevance of Pre-Operative C-Reactive Protein Levels in Colorectal Carcinoma Patients. Department of Surgery, Medical University of Vienna.
[8] Bannwarth, S., Giordanengo, V., Lesimple, J. and Lefebvre, J. (1998) Molecular Cloning of a New Secreted Sulfated Mucin-Like Protein with a C-Type Lectin Domain That Is Expressed in Lymphoblastic Cells. Journal of Biological Chemistry, 273, 1911-1916. [Google Scholar] [CrossRef] [PubMed]
[9] Ito, C., Sato, H., Ando, K., Watanabe, S., Yoshiba, F., Kishi, K., et al. (2003) Serum Stem Cell Growth Factor for Monitoring Hematopoietic Recovery Following Stem Cell Transplantation. Bone Marrow Transplantation, 32, 391-398. [Google Scholar] [CrossRef] [PubMed]
[10] Lin, T., Yang, C., Chou, H., Cheng, C., Liu, Y., Wang, J., et al. (2022) EGFR Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities. Cancers, 14, Article 1356. [Google Scholar] [CrossRef] [PubMed]
[11] Zheng, Q., Gong, Z., Li, B., Cheng, R., Luo, W., Huang, C., et al. (2024) Identification and Characterization of CLEC11A and Its Derived Immune Signature in Gastric Cancer. Frontiers in Immunology, 15, Article 1324959. [Google Scholar] [CrossRef] [PubMed]
[12] Wang, M., Guo, J., Zhang, L., Kuek, V., Xu, J. and Zou, J. (2020) Molecular Structure, Expression, and Functional Role of Clec11a in Skeletal Biology and Cancers. Journal of Cellular Physiology, 235, 6357-6365. [Google Scholar] [CrossRef] [PubMed]
[13] Yin, C., Zhang, J., Guan, W., Dou, L., Liu, Y., Shen, M., et al. (2021) High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia. Frontiers in Oncology, 11, Article 608932. [Google Scholar] [CrossRef] [PubMed]
[14] Bilotta, M.T., Antignani, A. and Fitzgerald, D.J. (2022) Managing the TME to Improve the Efficacy of Cancer Therapy. Frontiers in Immunology, 13, Article 954992. [Google Scholar] [CrossRef] [PubMed]
[15] Klemm, F. and Joyce, J.A. (2015) Microenvironmental Regulation of Therapeutic Response in Cancer. Trends in Cell Biology, 25, 198-213. [Google Scholar] [CrossRef] [PubMed]
[16] Elice, F., Rodeghiero, F., Falanga, A. and Rickles, F.R. (2009) Thrombosis Associated with Angiogenesis Inhibitors. Best Practice & Research Clinical Haematology, 22, 115-128. [Google Scholar] [CrossRef] [PubMed]
[17] Hinshaw, D.C. and Shevde, L.A. (2019) The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Research, 79, 4557-4566. [Google Scholar] [CrossRef] [PubMed]
[18] Dai, X., Ren, T., Zhang, Y. and Nan, N. (2021) Methylation Multiplicity and Its Clinical Values in Cancer. Expert Reviews in Molecular Medicine, 23, e2. [Google Scholar] [CrossRef] [PubMed]
[19] Li, Y., Jin, H., Li, Q., Shi, L., Mao, Y. and Zhao, L. (2024) The Role of RNA Methylation in Tumor Immunity and Its Potential in Immunotherapy. Molecular Cancer, 23, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
[20] Kuraishy, A., Karin, M. and Grivennikov, S.I. (2011) Tumor Promotion via Injury and Death-Induced Inflammation. Immunity, 35, 467-477. [Google Scholar] [CrossRef] [PubMed]
[21] Rybinski, B., Franco-Barraza, J. and Cukierman, E. (2014) The Wound Healing, Chronic Fibrosis, and Cancer Progression Triad. Physiological Genomics, 46, 223-244. [Google Scholar] [CrossRef] [PubMed]
[22] Metur, S.P., Lei, Y., Zhang, Z. and Klionsky, D.J. (2023) Regulation of Autophagy Gene Expression and Its Implications in Cancer. Journal of Cell Science, 136, jcs260631. [Google Scholar] [CrossRef] [PubMed]
[23] Cho, D.H., Jo, Y.K., Kim, S.C., et al. (2012) Down-Regulated Expression of ATG5 in Colorectal Cancer. Anticancer Research, 32, 4091-4096.